These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34374741)

  • 21. Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke.
    Goertler M; Blaser T; Krueger S; Hofmann K; Baeumer M; Wallesch CW
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):338-42. PubMed ID: 11861691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy in patients with cerebral microbleeds.
    Wilson D; Werring DJ
    Curr Opin Neurol; 2017 Feb; 30(1):38-47. PubMed ID: 27898582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
    Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
    PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
    Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
    Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
    Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
    Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
    BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
    Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
    Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to antithrombotic therapy after transient ischaemic attack and ischaemic stroke.
    Phan TG; Clissold B; Ma H
    Med J Aust; 2022 Jun; 216(10):495-497. PubMed ID: 35546263
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative antithrombotic treatment in acutely symptomatic carotid artery stenosis.
    Martinez-Gutierrez JC; Roy AT; D'Amato S; Berkman JM; Montes D; Kimball CA; Rordorf GA; Chibnik LB; Romero JM; Silverman SB
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106396. PubMed ID: 35219972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.
    Fuentes B; Gállego J; Gil-Nuñez A; Morales A; Purroy F; Roquer J; Segura T; Tejada J; Lago A; Díez-Tejedor E; ; Alonso de Leciñana M; Alvarez-Sabin J; Arenillas J; Calleja S; Casado I; Castellanos M; Castillo J; Dávalos A; Díaz-Otero F; Egido JA; López-Fernández JC; Freijo M; García Pastor A; Gilo F; Irimia P; Maestre J; Masjuan J; Martí-Fábregas J; Martínez-Sánchez P; Martínez-Vila E; Molina C; Nombela F; Ribó M; Rodríguez-Yañez M; Rubio F; Serena J; Simal P; Vivancos J;
    Neurologia; 2014 Apr; 29(3):168-83. PubMed ID: 21937151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
    Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
    J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
    Kim AS; Easton JD
    Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA.
    Pan Y; Wangqin R; Li H; Jin A; Li J; Lin J; Meng X; Xian Y; Laskowitz DT; Wang Y
    Stroke Vasc Neurol; 2022 Aug; 7(4):276-284. PubMed ID: 35256525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary prevention of stroke: a practical guide to drug treatment.
    Koennecke HC
    CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.